Leo Pavliv - SVP and Chief Development Off. at Cumberland Pharmaceuticals Inc

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	130K	$220K	$1.70	May 31, 2022	Direct
Options (right to buy)	0			Mar 16, 2022	Direct	Common Stock

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.